Bluepha
蓝晶微生物（北京蓝晶微生物科技有限公司）
A leading Chinese synthetic-biology / PHA-biopolymer company with large-scale fermentation — a sector benchmark for ultra-high-density fermentation, but not a Shenzhen/GBA visit target.
- Location
- Beijing (HQ); Yancheng, Jiangsu (production) · Other
- Source status
- medium confidenceresearched
Next action
Keep the dossier ready and use the open questions if a visit window opens.
Why now: Watchlist target in Other
What they do
Synthetic-biology and materials-innovation company producing PHA (polyhydroxyalkanoate) — a 100% bio-based, marine-degradable biopolymer made by microbial fermentation rather than petrochemistry, for packaging, fibres and injection-moulding. It uses diverse feedstocks (starch, plant oil, sugarcane) and pushes non-grain-feedstock conversion and ultra-high-density fermentation.
It runs a production base in Yancheng, Jiangsu (reported PHA capacity ~25,000 t/yr), reinvests roughly half of annual revenue into R&D, and has a strategic partnership with TotalEnergies Corbion.
Why it matters
A sector benchmark for large-scale microbial fermentation — specifically ultra-high-density fermentation and non-grain-feedstock conversion, which is the kind of biomanufacturing economics an AI-accelerated microbial-biocontrol platform must eventually hit. The value is learning how a leading Chinese synbio firm runs fermentation at tonnage and sustains heavy R&D reinvestment; they make a polymer, not an agri active, so there is no direct product tie — benchmark only.
Visit objective & route
Benchmark large-scale microbial fermentation economics as a remote reference; only pursue an in-person meeting if a Shenzhen/GBA office is confirmed, otherwise keep on the watchlist rather than as a GBA stop.
Approach route
Remote benchmarking; approach via the company website only if a GBA office is confirmed to exist.
Talking points
- How they run ultra-high-density fermentation and the economics behind it
- Approach to non-grain-feedstock conversion and feedstock flexibility
- How they scale microbial fermentation to tonnage and sustain ~50% revenue R&D reinvestment
- Whether any Shenzhen/GBA office exists that would make a visit feasible
Open questions
- Whether any Shenzhen/GBA office or site actually exists for a visit
- Current PHA production capacity (sources give conflicting figures)
- Total funding raised to date (reported but not independently confirmed)
- Whether PHA has any material relevance to Pure Advance's product lines (likely low)
Risks & unknowns
- Not a GBA site — HQ Beijing, production Yancheng — so this is remote benchmarking, not a Shenzhen visit
- Appointment-only; no confirmed GBA host
- Conflicting capacity figures and unconfirmed funding claims
- Polymer maker, not an agri active — no direct biocontrol product tie
Private-pack boundary